site

commit d35c29d690cc8353dacf5a39a08a2a88734b26c8
parent 9a3b704bb8152e9e45050d701943c6a40ac0bc6e
Author: Beau Hilton <beau.hilton@vumc.org>
Date:   Sun, 22 Aug 2021 14:39:25 -0500

img size

Diffstat:
M
posts/mr-2021.md
 | 
2
+-

1 file changed, 1 insertion(+), 1 deletion(-)
diff --git a/posts/mr-2021.md b/posts/mr-2021.md
@@ -90,7 +90,7 @@ Details modified, generalized, and otherwise fudged to be HIPAA-compliant.
 
 ## TLS
 
-![TLS](https://cdn.jamanetwork.com/ama/content_public/journal/oncology/937239/cpg180002fa.png?Expires=1632594426&Signature=y4M-w5gXSYJCAVMqGVEyfaPaqZocE9nGaWFnmr7GY7vuiD35l7dL-yJLWn4l3huTo4yBhri1nM0KjQ4dZBBjEYH5tPmKExEJ0D6V~WNou9Av-OEwhyQh79y9feHp790YWY6hTKRJJge958meDu~OmNl8Sl0Wn1N4buZZgVNMRdRds9fKbaDr4DhEdCbMgFbbLSeW9h8KIOm49Gog8FREQNntRaN1jILZgKPBTr9sUNv2BUiapZaLPO4teIf33LkJXcStx6o1VVsZJoP-G-sfMKG3ql1O~23E6LFJeirnMt5MYQdfk-LZlieuSw16HzqTXr-jBtOicDtyFzDJ9VcQ~g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA 'JAMA Oncology 2018, TLS Review'){width=50%}
+![TLS](https://cdn.jamanetwork.com/ama/content_public/journal/oncology/937239/cpg180002fa.png?Expires=1632594426&Signature=y4M-w5gXSYJCAVMqGVEyfaPaqZocE9nGaWFnmr7GY7vuiD35l7dL-yJLWn4l3huTo4yBhri1nM0KjQ4dZBBjEYH5tPmKExEJ0D6V~WNou9Av-OEwhyQh79y9feHp790YWY6hTKRJJge958meDu~OmNl8Sl0Wn1N4buZZgVNMRdRds9fKbaDr4DhEdCbMgFbbLSeW9h8KIOm49Gog8FREQNntRaN1jILZgKPBTr9sUNv2BUiapZaLPO4teIf33LkJXcStx6o1VVsZJoP-G-sfMKG3ql1O~23E6LFJeirnMt5MYQdfk-LZlieuSw16HzqTXr-jBtOicDtyFzDJ9VcQ~g__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA =500x500 'JAMA Oncology 2018, TLS Review')
 
 - laboratory vs clinical
 - risk assessment